yahoo Press
Barclays Maintains Overweight Rating on McKesson (MCK)
Images
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. McKesson Corporation (NYSE:MCK) is one of the Top 10 Strong Buy Stocks to Invest In. On June 10, 2026, Barclays lowered the firm’s price target on McKesson Corporation (NYSE:MCK) to $925 from $1,050 and maintained an Overweight rating on the shares. Barclays updated estimates and targets in the drug distributor space following recent results. The firm said its new estimates are “incrementally conservative” due to limited visibility around the Inflation Reduction Act, biosimilars, and GLP-1s, though it continues to believe in McKesson’s long-term model. On June 1, 2026, McKesson Corporation (NYSE:MCK) announced the completion of the previously announced minority ownership investment from funds managed by affiliates of Apollo (APO) in McKesson’s Medical-Surgical Solutions business. Apollo Funds invested $1.25B in convertible preferred equity of MMS to acquire an approximately 13% interest in the business. The transaction values MMS at approximately $13B in total enterprise value, while McKesson retains operating control and majority ownership. Last month, UBS analyst Kevin Caliendo raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $1,050 from $1,000 and maintained a Buy rating on the shares. Caliendo said that despite the “messy” Q4 print, the initial FY27 outlook looks “good enough.” McKesson Corporation (NYSE:MCK) provides healthcare services in the United States and internationally. While we acknowledge the potential of MCK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Comments
You must be logged in to comment.